Cencora, Inc. (COR) Covered Calls

Cencora, Inc. covered calls Cencora, Inc. is a leading global pharmaceutical sourcing and distribution services company. It plays a critical role in the healthcare supply chain, providing drug distribution and consulting services to healthcare providers and pharmaceutical manufacturers across the United States and international markets.

You can sell covered calls on Cencora, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for COR (prices last updated Tue 4:16 PM ET):

Cencora, Inc. (COR) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
364.38 -1.65 360.89 369.50 902K 44 71
Covered Calls For Cencora, Inc. (COR)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Mar 20 360 11.60 357.90 0.6% 8.8%
Apr 17 360 17.30 352.20 2.2% 15.2%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Cencora, Inc. (NYSE: COR), headquartered in Conshohocken, Pennsylvania, is a vital architect of the global pharmaceutical supply chain. Formerly known as AmerisourceBergen, the company rebranded to reflect its unified global identity and its evolution beyond simple wholesaling. Cencora sits at the intersection of drug manufacturers and healthcare providers, managing the complex logistics of getting life-saving medications to hospitals, retail pharmacies, and physician practices. Its business model is characterized by massive scale and razor-thin margins, where profitability is driven by volume, efficiency, and an increasing focus on high-margin specialty pharmaceutical services, such as oncology and cell therapy distribution.

Core Business and Products

  1. U.S. Healthcare Solutions: The company’s largest segment, distributing a comprehensive range of brand-name, generic, and specialty pharmaceuticals. It also provides practice management and consulting services specifically for independent pharmacies and oncology clinics.
  2. International Healthcare Solutions: Manages pharmaceutical wholesale and distribution operations across Europe and other global markets, including World Courier, a leader in premium global specialty logistics for clinical trials.
  3. Specialty & Physician Services: Through platforms like OneOncology, Cencora partners directly with specialty physician practices, providing them with the procurement power and administrative tools needed to remain independent while delivering complex care.
  4. Commercialization Services: Offers pharmaceutical manufacturers market access consulting, patient assistance program management, and data analytics to help bring new therapies to market efficiently.

Competitive Landscape

Cencora operates in a highly consolidated "Big Three" oligopoly that controls over 90% of the U.S. pharmaceutical distribution market. Its primary optionable rivals are McKesson Corporation and Cardinal Health. While McKesson is the leader by total revenue, Cencora distinguishes itself through its deep specialization in the "Specialty" market, particularly in oncology. It also competes with healthcare giants like Elevance Health in the pharmacy benefit management and services space. Cencora’s competitive advantage is rooted in its long-term distribution agreements with major retail partners like Walgreens Boots Alliance.

Strategic Outlook and Innovation

The long-term strategy for Cencora is defined by a shift from "distribution" to "value-added services." The company is aggressively expanding its presence in the specialty pharmaceutical arena, which includes complex biologics and biosimilars that require specialized cold-chain logistics. By integrating its distribution network with physician practice management, Cencora is creating a "sticky" ecosystem that is difficult for competitors to disrupt. This evergreen approach focuses on the secular tailwind of an aging global population and the continuous pipeline of innovative, high-cost specialty drugs that require the precise logistical expertise Cencora provides.

Innovation at Cencora is focused on the digital "intelligent supply chain" and the application of AI in clinical trial logistics. The company is deploying predictive analytics to optimize inventory levels across its global distribution centers, reducing waste and ensuring medication availability during regional health crises. Through World Courier, Cencora is pioneering the use of real-time sensor technology and autonomous tracking for cell and gene therapies, which often have extremely limited shelf lives and strict temperature requirements. By merging its industrial-scale distribution legacy with high-touch clinical services and data-driven insights, Cencora aims to remain the indispensable partner for the global pharmaceutical industry.